Grégory Chapron
Chief Operating Officer at Splio SAS
Profile
Grégory Chapron is currently the Chief Operating Officer at Splio SAS since 2020.
Previously, he worked as the Chief Financial Officer at Domain Therapeutics SA and as a Manager at Sirene Capital Oy.
He also served as the Chief Financial Officer at Nextedia SA from 2005 to 2008.
Mr. Chapron completed his undergraduate studies at École des Hautes Études Commerciales de Paris and AgroParisTech.
Grégory Chapron active positions
| Companies | Position | Start |
|---|---|---|
Splio SAS
 Splio SAS Packaged SoftwareTechnology Services Splio SAS provides computer programming services. Its application delivers an online and offline customer loyalty marketing to manage marketing campaigns and loyalty programs. The company was founded by Raphael Jore and Louis Rouxel in 2001 and is headquartered in Paris, France. | Chief Operating Officer | 01/11/2020 |
Former positions of Grégory Chapron
| Companies | Position | End |
|---|---|---|
| NEXTEDIA | Director of Finance/CFO | 01/01/2008 |
Sirene Capital Oy
 Sirene Capital Oy Electronics DistributorsDistribution Services Sirene Capital Oy develops software products and solutions. The company was founded by Tuomas Petri Juhani Fabritius and Mikko Alasaarela on June 1, 1999 and is headquartered in Oulu, Finland. | Corporate Officer/Principal | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Director of Finance/CFO | - |
Training of Grégory Chapron
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
| AgroParisTech | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEXTEDIA | Commercial Services |
| Private companies | 3 |
|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Sirene Capital Oy
Sirene Capital Oy Electronics DistributorsDistribution Services Sirene Capital Oy develops software products and solutions. The company was founded by Tuomas Petri Juhani Fabritius and Mikko Alasaarela on June 1, 1999 and is headquartered in Oulu, Finland. | Distribution Services |
Splio SAS
Splio SAS Packaged SoftwareTechnology Services Splio SAS provides computer programming services. Its application delivers an online and offline customer loyalty marketing to manage marketing campaigns and loyalty programs. The company was founded by Raphael Jore and Louis Rouxel in 2001 and is headquartered in Paris, France. | Technology Services |
- Stock Market
- Insiders
- Grégory Chapron
